Announcements Trials
Browse Landscape

Status

Completed 18Recruiting 12Active not recruiting 4Unknown 3Withdrawn 2Terminated 2Suspended 1Not yet recruiting 1Enrolling by invitation 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Thoracic 4Breast 3Tumor-Agnostic 2Other hematologic neoplasm 2Gynecologic 2Gastrointestinal 2CNS 2Head & Neck 1Endocrine 1

Conditions

Vulvar Neoplasms 1Vomiting 1Uterine Cervical Neoplasms 1Stomach Neoplasms 1Pancreatic Neoplasms 1Non-resectable Metastatic Cancer of the Lung 1Nausea 1Endometrial Neoplasms 1Anus Neoplasms 1

Interventions

Fluorouracil 145Gemcitabine 141Oxaliplatin 135Capecitabine 133Leucovorin 107Irinotecan 99Bevacizumab 92Cetuximab 69Cisplatin 67pembrolizumab 61Radiotherapy 60Nivolumab 41130-nm albumin-bound paclitaxel 41Sorafenib 39Docetaxel 34Albumin-Bound Paclitaxel 31Radiosurgery 28Paclitaxel 27Surgical Procedures, Operative 25regorafenib 24Erlotinib Hydrochloride 23Panitumumab 22Cyclophosphamide 21Celecoxib 20Trastuzumab 19Radiation 18Neoadjuvant Therapy 18IFL protocol 18atezolizumab 17Carboplatin 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Interviews as Topic × Gastrointestinal × Clear all
NCT03328065 2022-04-21

EOLE

Centre Hospitalier Universitaire Dijon

Terminated
36 enrolled
EndocrineGastrointestinal

Non-resectable Metastatic Cancer of the Lung

NCT00394602 2020-01-02

Chemoradiation-Induced Nausea and Emesis: Quality of Life

M.D. Anderson Cancer Center

Terminated
207 enrolled
GastrointestinalGynecologic

Anus Neoplasms, Uterine Cervical Neoplasms, Nausea, Pancreatic Neoplasms, Stomach Neoplasms, Vomiting, Vulvar Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡